Company Monitoring Page for Incyte

latest headlines for company on cafepharma

FDA delays decision on Lilly and Incyte's arthritis drug
BioPharma Dive
Tue, 01/17/17 - 11:04 am
Tags:
FDA, Eli Lilly, Incyte, rheumatoid arthritis, baricitinib
What Were Incyte’s Revenue Streams in 3Q16?
Market Realist
Sat, 01/7/17 - 12:38 pm
Tags:
Incyte, Jakafi, Iclusig
Biotech Investing: 3 Bold Predictions for 2017
Motley Fool
Fri, 01/6/17 - 09:47 am
Tags:
biotech, Incyte, Biogen, Biomarin, Gilead Sciences, Illumina
Biotech Stocks: What to Watch in 2017
Motley Fool
Tue, 01/3/17 - 10:02 am
Tags:
biotech, M&A, drug launches, Gilead Sciences, Incyte, Spinraza, Biogen, Ionis Pharmaceuticals, Amgen, Regeneron, Sanofi
The Most Likely Incyte Acquisition Deal for 2017?
Motley Fool
Sat, 12/24/16 - 12:11 pm
Tags:
M&A, Incyte, Gilead Sciences, Lilly, Novartis, Agenus
Incyte puts up $200M in bispecifics deal with Merus
BioPharma Dive
Thu, 12/22/16 - 10:21 am
Tags:
Incyte, Merus, bispecific antibodies
Gilead Fails to Beat Incyte’s Jakafi Drug
Investopedia
Sat, 11/19/16 - 11:32 am
Tags:
Gilead Sciences, Jakafi, Incyte, momelotinib, myelofibrosis
Should Gilead Sciences Purchase Incyte?
Seeking Alpha
Fri, 11/18/16 - 10:02 am
Tags:
Gilead Sciences, Incyte, M&A
3 Biotechs Most Likely to Be Acquired
Motley Fool
Tue, 10/11/16 - 09:45 pm
Tags:
biotech, M&A, Incyte, Biomarin, Biogen
Updated Incyte combo data for epacadostat/Keytruda look promising
Endpoints
Fri, 10/7/16 - 09:09 am
Tags:
Incyte, epacadostat, Keytruda
Incyte Could Be A Takeover Target, Argus Lifts Price Target To $98
Yahoo/Benzinga
Tue, 09/27/16 - 10:04 pm
Tags:
Incyte, M&A
After Losing Medivation, Who Is Gilead Going After Next?
Forbes
Mon, 09/19/16 - 03:39 pm
Tags:
Medivation, Gilead Sciences, M&A, Puma Biotechnology, Kite Pharma, Incyte, Portola Pharmaceuticals
3 Biotech Stocks Could Be the Next Big Takeover Targets
24/7 Wall St
Wed, 08/31/16 - 09:20 am
Tags:
biotech, M&A, Biomarin, Incyte, Tesaro
4 Biotech Buyout Targets for Gilead, Sanofi After Medivation Miss
Barron's
Tue, 08/23/16 - 11:11 am
Tags:
biotech, M&A, Gilead Sciences, Sanofi, Medivation, Incyte, Biomarin, Tesaro, Seattle Genetics
3 Plausible Buyout Scenarios Within Biotech
Seeking Alpha
Tue, 07/5/16 - 10:20 am
Tags:
biotech, Acadia, AstraZeneca, Allergan, Biogen, Teva Pharmaceutical, Biomarin, Incyte, Ironwood, Medivation, Pfizer, Relypsa, Synergy Pharmaceuticals, M&A
These 15 Biotech Companies Could Be Takeover Targets
Barron's
Wed, 06/29/16 - 12:56 pm
Tags:
biotech, M&A, Alder Biopharmaceuticals, Biomarin, Coherus Biosciences, Intercept Pharma, Ultragenyx, Seattle Genetics, Adamas Pharmaceuticals, Alexion, Clovis Oncology, Corbus Pharmaceuticals, Incyte, Prothena, Puma Biotechnology, Tesaro, Versartis
FDA Grants Breakthrough Therapy Designation for Incyte’s Ruxolitinib (Jakafi®) in Acute Graft-Versus-Host Disease (GVHD)
Yahoo
Fri, 06/24/16 - 09:15 am
Tags:
FDA, Incyte, Jakafi, breakthrough therapies, graft vs host disease
Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs
Yahoo
Thu, 06/9/16 - 10:10 am
Tags:
baricitinib, Eli Lilly, Incyte, rheumatoid arthritis
Biotech: Is the Rally Real?
Barron's
Thu, 06/2/16 - 04:01 pm
Tags:
biotech, Prothena, Biomarin, Vertex Pharmaceuticals, Incyte, Celgene
3 Big Battles Brewing in Biotech
Motley Fool
Sun, 04/10/16 - 01:50 pm
Tags:
AstraZeneca, ZS-9, Relypsa, Veltassa, Synergy Pharmaceuticals, plecanatide, Linzess, Ironwood, Allergan, Incyte, Eli Lilly, baricitinib, AbbVie, Humira

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.